Interview with the Founder, COO and President and the Chief Science Officer: Digipath, Inc. (OTCMKTS:DIGP)

Healthcare >> CEO Interviews >> October 21, 2016

Todd Denkin is Founder, Chairman, CEO and President of Digipath, Inc. Since joining Digipath, Inc. in 2014, Mr. Denkin moved the company from a pure digital pathology solution provider into a leader in the medical and recreational cannabis testing market. Digipath Labs’ Las Vegas cannabis testing facility is the number-one testing lab in Nevada. It has been operating since May 2015 and seen a steady increase in clients and revenues. While maintaining the highest standard for cannabis testing, Mr. Denkin also focuses on expanding the business through licensing agreements and partnerships. This brings the reliability, experience and customer service Digipath Labs is known for to cannabis markets across the country. Mr. Denkin’s career has been defined by foresight — the ability to spot and take advantage of emerging market trends and navigate new companies into lucrative markets. In 2009, Mr. Denkin identified a trend in grow-your-own hydroponic systems and co-founded the self-contained hydroponic system leader Phototron Holdings. He helped take the company public and served as its President. At the time, it was one of the very first publicly traded cannabis companies. Starting in the television and film production business since attending the University of Florida, Mr. Denkin became a 25-year show business veteran, making TV shows, commercials, infomercials, music videos and films. It was another natural fit for Mr. Denkin to shift to the internet in 2000 with a streaming video dot-com startup in Las Vegas, Nevada. He helped take that company public in 2003. Profile

Cindy Orser, Ph.D., as Chief Science Officer at Digipath Labs for Digipath, Inc., was responsible for the initial conceptualization, development and rollout of the company’s industry-leading standardized botanical nutraceutical testing facilities. Dr. Orser draws from over 20 years of experience innovating in academia and private industry. She has been the liaison between her company, Big Sky Biosystems Inc., and regulatory compliance agencies, including the FDA, CDC and DHS. Her responsibilities have included conceptualizing and managing key projects, lab benchmarking, fundraising and budgeting, staffing, managing personnel, identifying outside collaborators and directing subcontractors. Profile

TWST: Can you give us a description and brief history of the company?

Mr. Denkin: Digipath was founded back in 2010 in Las Vegas, Nevada, when we were in the

Join for free to read a longer excerpt or purchase this article

Interview with the Founder, COO and President and the Chief Science Officer: Digipath, Inc. (OTCMKTS:DIGP)

Top Company Interviews

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS

Interview with the Founder, COO and President and the Chief Science Officer: Digipath, Inc. (OTCMKTS:DIGP)

Top Company Interviews

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS